Pathological complete response of renal cell carcinoma with vena cava tumor thrombus to neoadjuvant TKI/IO combination therapy
Author:
Publisher
Elsevier BV
Subject
Urology
Reference5 articles.
1. The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma;Borregales;Ther Adv Urol,2016
2. Total necrosis after sequential treatment with pazopanib followed by nivolumab in a patient with renal cell carcinoma involving the inferior vena cava;Shiraishi;Int J Urol,2019
3. Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy;Craig;J Immunother Cancer,2019
4. Improved survival after cytoreductive nephrectomy for metastatic renal cell carcinoma in the contemporary immunotherapy era: an analysis of the National Cancer Database;Nirmish;Urol Oncol,2020
5. Vascular endothelial growth factor-targeted treatment suppresses angiogenesis and reprograms the immune microenvironment. Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment;Yi;Mol Canc,2019
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and safety of neoadjuvant therapy with tislelizumab plus axitinib for nonmetastatic renal cell carcinoma with inferior vena cava tumor thrombus: a retrospective study;2024-08-17
2. Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial;Journal for ImmunoTherapy of Cancer;2024-06
3. Neoadjuvant therapy in renal cell carcinoma with tumor thrombus: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2024-04
4. A case of postoperative pancreatitis in patients with renal cell carcinoma with an inferior vena cava tumor thrombus treated by presurgical lenvatinib plus pembrolizumab;International Cancer Conference Journal;2024-02-14
5. Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis;Case Reports in Oncology;2024-01-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3